Contact this trialFirst, we need to learn more about you.
Electrolyte Modifying Agent
SZC for High Potassium in Heart Failure Patients
Recruiting2 awardsPhase 4
New Brunswick, New Jersey
This trial tests if SZC can keep potassium levels normal in heart failure patients taking spironolactone. SZC acts like a sponge to soak up extra potassium and remove it from the body. SZC is a newly introduced treatment that effectively lowers and maintains normal potassium levels in patients with high potassium.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service